Cannabis Campaigners' Guide News Database result:


After you have finished reading this article you can click here to go back.

UK: Dope hopes

The Mirror

Thursday 17 Jan 2002

---

GW Pharma, the only group in Britain with a licence to grow cannabis,
yesterday saw its shares jump to as high as 117p.

The biotech firm aims to test its new cannabis-based drug for pain
relief on patients with terminal cancer. It's also launching trials for
multiple sclerosis sufferers and spinal cord injury patients. The
shares, up from 103p four weeks ago, closed at 114p.

 

 

 

After you have finished reading this article you can click here to go back. 




This page was created by the Cannabis Campaigners' Guide.

Feel free to link to this page!